Friday 29 Mar 2024
By
main news image

SINGAPORE (June 26): Clearbridge Health (CBH) is partnering Australia-based health information company Genome.One, a wholly-owned subsidiary of Garvan Institute of Medical Research, to offer its patients genomic testing and analysis with the latter’s Genome.One GoExplore personal health genomics programme.

The programme sequences and analyses individual DNA samples assess their risk of developing 52 hereditary conditions, including 31 cancers, 13 heart conditions, as well as several other conditions where monitoring or intervention can be of benefit.

The test will also determine patients’ likely response to over...(click on link for full story on theedgesingapore.com)
 

      Print
      Text Size
      Share